Evaluation of Sch 29,482 in the eradication of Neisseria meningitidis from nasopharyngeal carriers.
Fifty-eight chronic carriers of Neisseria meningitidis were given 250 mg of Sch 29,482 or placebo orally every 6 h for 4 days. Although 22 of 29 subjects taking Sch 29,482 became culture negative while taking the drug, only five were culture negative 2 weeks posttherapy. There were no significant ad...
Saved in:
| Published in: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Microbiology (ASM)
1984
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185560/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6732217/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.4.494 |
| Tags: |
No Tags, Be the first to tag this record!
|